Abstract
End stage renal disease is a serious complication in heart or heart–lung transplant recipients and is associated with high morbidity and mortality. The majority of these patients are currently treated with hemodialysis. Since there are no randomized control trials comparing hemodialysis to peritoneal dialysis in this patient population, the potential beneficial effects of peritoneal dialysis remain largely unknown. We compared the clinical outcome of such patients on peritoneal dialysis with another group on hemodialysis. Our results indicate that patients on peritoneal dialysis had fewer episodes of congestive heart failure, fluid overload and a lower overall hospitalization rate, despite having worse cardiac function than patients on hemodialysis.
Similar content being viewed by others
References
Van de Wetering J, Weimar CH, Balk AH, Roodnat JI, Holweg CT, Baan CC, van Domburg RT, Weimar W (2006) The impact of transforming growth factor-beta1 gene polymorphism on end-stage renal failure after heart transplantation. Transplantation 82:1744–1748
Alam A, Badovinac K, Ivis F, Trpeski L, Cantarovich M (2007) The outcome of heart transplant recipients following the development of end-stage renal disease: analysis of the Canadian Organ Replacement Register (CORR). Am J Transplant 7:461–465
Yang X, Fang W, Kothari J, Khandelwal M, Naimark D, Jassal SV, Bargman JM, Oreopoulos DG (2007) Clinical outcomes of elderly patients undergoing chronic peritoneal dialysis: experiences from one center and a review of the literature. Int Urol Nephrol 39:1295–1302
Giannattasio M, Buemi M, Caputo F, Viglino G (2003) Can peritoneal dialysis be used as a long term therapy for end stage renal disease? Int Urol Nephrol 35:569–577
Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, Arndorfer J, Christensen L, Merion RM (2003) Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349:931–940
Pattison JM, Petersen J, Kuo P, Valantine V, Robbins R, Theodore J (1995) The incidence of renal failure in one hundred consecutive heart–lung recipients. Am J Kidney Dis 26:643–648
Goldstein DJ, Zuech N, Sehgal V, Weinberg AD, Drusin R, Cohen D (1997) Cyclosporine-associated end-stage nephropathy after cardiac transplantation: incidence and progression. Transplantation 63:664–668
Jayasena SD, Riaz A, Lewis CM, Neild GH, Thompson FD, Woolfson RG (2001) Outcome in patients with end-stage renal disease following heart or heart–lung transplantation receiving peritoneal dialysis. Nephrol Dial Transplant 16:1681–1685
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ahmad, M., Robert, R., Bargman, J.M. et al. Advantages of peritoneal dialysis in comparison to hemodialysis, in cardiac allograft recipients with end stage renal disease. Int Urol Nephrol 40, 1083–1087 (2008). https://doi.org/10.1007/s11255-008-9406-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-008-9406-z